Last reviewed · How we verify
Tranexamic Acid Oral Product
Tranexamic Acid Oral Product is a Small molecule drug developed by Alejandro Reyes Sánchez. It is currently FDA-approved. Also known as: TA.
Tranexamic Acid Oral Product is used to study the treatment of hemorrhage postoperative, total blood loss, arthroplasty complications, pigmentation, and pigmentation disorder in clinical trials. It is being investigated as a noninferior alternative to intravenous administration in total hip arthroplasty, as shown in the clinical trial "Study of the Noninferiority of an Oral vs Intravenous Administration of Tranexamic Acid in Total Hip Arthroplasty".
At a glance
| Generic name | Tranexamic Acid Oral Product |
|---|---|
| Also known as | TA |
| Sponsor | Alejandro Reyes Sánchez |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery (EARLY_PHASE1)
- Enhanced Recovery After Surgery in Orthopaedic Spine Surgery (PHASE2, PHASE3)
- The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma (PHASE3)
- Perioperative Treatment With Tranexamic Acid in Melanoma (PHASE3)
- Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding (NA)
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
- Pharmacokinetics and Pharmacodynamics of Tranexamic Acid in Women Having Caesarean Section Birth [WOMAN-PharmacoTXA] (PHASE2)
- Effects of RF Microneedle on Photoaging Skin (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tranexamic Acid Oral Product CI brief — competitive landscape report
- Tranexamic Acid Oral Product updates RSS · CI watch RSS
- Alejandro Reyes Sánchez portfolio CI
Frequently asked questions about Tranexamic Acid Oral Product
What is Tranexamic Acid Oral Product?
Who makes Tranexamic Acid Oral Product?
Is Tranexamic Acid Oral Product also known as anything else?
What development phase is Tranexamic Acid Oral Product in?
Related
- Manufacturer: Alejandro Reyes Sánchez — full pipeline
- Also known as: TA
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing